98 related articles for article (PubMed ID: 26196275)
1. Investigation on the aerosol performance of dry powder inhalation hypromellose capsules with different lubricant levels.
Saleem IY; Diez F; Jones BE; Kayali N; Polo L
Int J Pharm; 2015 Aug; 492(1-2):258-63. PubMed ID: 26196275
[TBL] [Abstract][Full Text] [Related]
2. Statistical tools and control of internal lubricant content of inhalation grade HPMC capsules during manufacture.
Ayala G; Díez F; Gassó MT; Jones BE; Martín-Portugués R; Ramiro-Aparicio J
Int J Pharm; 2016 Apr; 503(1-2):36-40. PubMed ID: 26899981
[TBL] [Abstract][Full Text] [Related]
3. Impact of capsule type on aerodynamic performance of inhalation products: A case study using a formoterol-lactose binary or ternary blend.
Wauthoz N; Hennia I; Ecenarro S; Amighi K
Int J Pharm; 2018 Dec; 553(1-2):47-56. PubMed ID: 30321640
[TBL] [Abstract][Full Text] [Related]
4. Correlations between surface composition and aerosolization of jet-milled dry powder inhaler formulations with pharmaceutical lubricants.
Mangal S; Park H; Nour R; Shetty N; Cavallaro A; Zemlyanov D; Thalberg K; Puri V; Nicholas M; Narang AS; Zhou QT
Int J Pharm; 2019 Sep; 568():118504. PubMed ID: 31299339
[TBL] [Abstract][Full Text] [Related]
5. Carrier-based dry powder inhalation: Impact of carrier modification on capsule filling processability and in vitro aerodynamic performance.
Faulhammer E; Wahl V; Zellnitz S; Khinast JG; Paudel A
Int J Pharm; 2015 Aug; 491(1-2):231-42. PubMed ID: 26136200
[TBL] [Abstract][Full Text] [Related]
6. "Pierce and inhale" design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs.
Martinelli F; Balducci AG; Rossi A; Sonvico F; Colombo P; Buttini F
Int J Pharm; 2015 Jun; 487(1-2):197-204. PubMed ID: 25843756
[TBL] [Abstract][Full Text] [Related]
7. The development of a sensitive methodology to characterise hard shell capsule puncture by dry powder inhaler pins.
Torrisi BM; Birchall JC; Jones BE; Díez F; Coulman SA
Int J Pharm; 2013 Nov; 456(2):545-52. PubMed ID: 23965433
[TBL] [Abstract][Full Text] [Related]
8. Comparison of HPMC Inhalation-Grade Capsules and Their Effect on Aerosol Performance Using Budesonide and Rifampicin DPI Formulations.
Ding L; Brunaugh AD; Thakkar R; Lee C; Zhao QJ; Kalafat J; Maniruzzaman M; Smyth HDC
AAPS PharmSciTech; 2022 Jan; 23(1):52. PubMed ID: 35018574
[TBL] [Abstract][Full Text] [Related]
9. Extrinsic lactose fines improve dry powder inhaler formulation performance of a cohesive batch of budesonide via agglomerate formation and consequential co-deposition.
Kinnunen H; Hebbink G; Peters H; Huck D; Makein L; Price R
Int J Pharm; 2015 Jan; 478(1):53-59. PubMed ID: 25448567
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the sensitivity, reproducibility and flexibility of a method to test hard shell capsules intended for use in dry powder inhalers.
Chong RH; Jones BE; Díez F; Birchall JC; Coulman SA
Int J Pharm; 2016 Mar; 500(1-2):316-25. PubMed ID: 26806464
[TBL] [Abstract][Full Text] [Related]
11. Formulating powder-device combinations for salmeterol xinafoate dry powder inhalers.
Hassoun M; Ho S; Muddle J; Buttini F; Parry M; Hammond M; Forbes B
Int J Pharm; 2015 Jul; 490(1-2):360-7. PubMed ID: 25987210
[TBL] [Abstract][Full Text] [Related]
12. Influence of capsule shell composition on the performance indicators of hypromellose capsule in comparison to hard gelatin capsules.
Al-Tabakha MM; Arida AI; Fahelelbom KM; Sadek B; Saeed DA; Abu Jarad RA; Jawadi J
Drug Dev Ind Pharm; 2015; 41(10):1726-37. PubMed ID: 25586554
[TBL] [Abstract][Full Text] [Related]
13. Improved aerosolization performance of salbutamol sulfate formulated with lactose crystallized from binary mixtures of ethanol-acetone.
Kaialy W; Ticehurst MD; Murphy J; Nokhodchi A
J Pharm Sci; 2011 Jul; 100(7):2665-84. PubMed ID: 21268026
[TBL] [Abstract][Full Text] [Related]
14. Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.
Singh DJ; Jain RR; Soni PS; Abdul S; Darshana H; Gaikwad RV; Menon MD
J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):254-67. PubMed ID: 25517187
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Physico-mechanical Properties and Electrostatic Charging Behavior of Different Capsule Types for Inhalation Under Distinct Environmental Conditions.
Pinto JT; Wutscher T; Stankovic-Brandl M; Zellnitz S; Biserni S; Mercandelli A; Kobler M; Buttini F; Andrade L; Daza V; Ecenarro S; Canalejas L; Paudel A
AAPS PharmSciTech; 2020 May; 21(4):128. PubMed ID: 32399597
[TBL] [Abstract][Full Text] [Related]
16. Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.
Kaialy W; Ticehurst M; Nokhodchi A
Int J Pharm; 2012 Feb; 423(2):184-94. PubMed ID: 22197772
[TBL] [Abstract][Full Text] [Related]
17. An insight into powder entrainment and drug delivery mechanisms from a modified Rotahaler®.
Sim S; Margo K; Parks J; Howell R; Hebbink GA; Orlando L; Larson I; Leslie P; Ho L; Morton DA
Int J Pharm; 2014 Dec; 477(1-2):351-60. PubMed ID: 25196720
[TBL] [Abstract][Full Text] [Related]
18. Moisture diffusion and permeability characteristics of hydroxypropylmethylcellulose and hard gelatin capsules.
Barham AS; Tewes F; Healy AM
Int J Pharm; 2015 Jan; 478(2):796-803. PubMed ID: 25526672
[TBL] [Abstract][Full Text] [Related]
19. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the puncturing properties of gelatin and hypromellose capsules for use in dry powder inhalers.
Birchall JC; Jones BE; Morrissey A; Jones BE
Drug Dev Ind Pharm; 2008 Aug; 34(8):870-6. PubMed ID: 18686093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
